A Calcium-Dependent Protease As a Potential Therapeutic Target for Wolfram Syndrome
A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome Simin Lua,b, Kohsuke Kanekuraa, Takashi Haraa, Jana Mahadevana, Larry D. Spearsa, Christine M. Oslowskic, Rita Martinezd, Mayu Yamazaki-Inouee, Masashi Toyodae, Amber Neilsond, Patrick Blannerd, Cris M. Browna, Clay F. Semenkovicha, Bess A. Marshallf, Tamara Hersheyg, Akihiro Umezawae, Peter A. Greerh, and Fumihiko Uranoa,i,1 aDepartment of Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110; bGraduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA 01655; cDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118; dDepartment of Genetics, iPSC core facility, Washington University School of Medicine, St. Louis, MO 63110; eDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan; fDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110; gDepartments of Psychiatry, Neurology, and Radiology, Washington University School of Medicine, St. Louis, MO 63110; hDepartment of Pathology and Molecular Medicine, Queen’s University, Division of Cancer Biology and Genetics, Queen’s Cancer Research Institute, Kingston, Ontario K7L3N6, Canada; and iDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110 Edited by Stephen O’Rahilly, University of Cambridge, Cambridge, United Kingdom, and approved November 7, 2014 (received for review November 4, 2014) Wolfram syndrome is a genetic disorder characterized by diabetes gene variants are also associated with a risk of type 2 diabetes (17). and neurodegeneration and considered as an endoplasmic re- Moreover, a specific WFS1 variant can cause autosomal dominant ticulum (ER) disease.
[Show full text]